{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T03:34:35Z","timestamp":1761708875005},"reference-count":48,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2013,6,7]],"date-time":"2013-06-07T00:00:00Z","timestamp":1370563200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0065641","type":"journal-article","created":{"date-parts":[[2013,6,8]],"date-time":"2013-06-08T15:11:27Z","timestamp":1370704287000},"page":"e65641","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":44,"title":["Concurrent Activation of Liver X Receptor and Peroxisome Proliferator-Activated Receptor Alpha Exacerbates Hepatic Steatosis in High Fat Diet-Induced Obese Mice"],"prefix":"10.1371","volume":"8","author":[{"given":"Mingming","family":"Gao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Le","family":"Bu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongjie","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dexi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2013,6,7]]},"reference":[{"key":"ref1","first-page":"31","article-title":"Biological role of liver X receptors","volume":"59","author":"M Baranowski","year":"2008","journal-title":"J Physiol Pharmacol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.2337\/diabetes.53.2007.S43","article-title":"The biology of peroxisome proliferator-activated receptors: relationship with lipid metabolism and insulin sensitivity","volume":"53","author":"P Ferre","year":"2004","journal-title":"Diabetes"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1110\/ps.04951405","article-title":"Ligand-binding regulation of LXR\/RXR and LXR\/PPAR heterodimerizations: SPR technology-based kinetic analysis correlated with molecular dynamics simulation","volume":"14","author":"L Yue","year":"2005","journal-title":"Protein Sci"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1210\/me.2002-0191","article-title":"Cross-talk between peroxisome proliferator-activated receptor (PPAR) alpha and liver X receptor (LXR) in nutritional regulation of fatty acid metabolism. II. LXRs suppress lipid degradation gene promoters through inhibition of PPAR signaling","volume":"17","author":"T Ide","year":"2003","journal-title":"Mol Endocrinol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1210\/me.2002-0190","article-title":"Cross-talk between peroxisome proliferator-activated receptor (PPAR) alpha and liver X receptor (LXR) in nutritional regulation of fatty acid metabolism. I. PPARs suppress sterol regulatory element binding protein-1c promoter through inhibition of LXR signaling","volume":"17","author":"T Yoshikawa","year":"2003","journal-title":"Mol Endocrinol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1074\/jbc.M210208200","article-title":"Antidiabetic action of a liver X receptor agonist mediated by inhibition of hepatic gluconeogenesis","volume":"278","author":"G Cao","year":"2003","journal-title":"J Biol Chem"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"5419","DOI":"10.1073\/pnas.0830671100","article-title":"Activation of liver X receptor improves glucose tolerance through coordinate regulation of glucose metabolism in liver and adipose tissue","volume":"100","author":"BA Laffitte","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1208\/s12248-012-9429-3","article-title":"The liver X receptor agonist T0901317 protects mice from high fat diet-induced obesity and insulin resistance","volume":"15","author":"M Gao","year":"2013","journal-title":"AAPS J"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1194\/jlr.M800376-JLR200","article-title":"Synthetic LXR agonist attenuates plaque formation in apoE\u2212\/\u2212 mice without inducing liver steatosis and hypertriglyceridemia","volume":"50","author":"A Kratzer","year":"2009","journal-title":"J Lipid Res"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"3038","DOI":"10.1007\/s00125-006-0472-4","article-title":"Liver X receptor agonists ameliorate TNFalpha-induced insulin resistance in murine brown adipocytes by downregulating protein tyrosine phosphatase-1B gene expression","volume":"49","author":"S Fernandez-Veledo","year":"2006","journal-title":"Diabetologia"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1194\/jlr.M300135-JLR200","article-title":"The LXR ligand T0901317 induces severe lipogenesis in the db\/db diabetic mouse","volume":"44","author":"JW Chisholm","year":"2003","journal-title":"J Lipid Res"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1586\/14779072.6.10.1319","article-title":"Fenofibrate: treatment of hyperlipidemia and beyond","volume":"6","author":"RS Rosenson","year":"2008","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1172\/JCI6223","article-title":"Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting","volume":"103","author":"S Kersten","year":"1999","journal-title":"J Clin Invest"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"E270","DOI":"10.1152\/ajpendo.2001.280.2.E270","article-title":"A potent PPAR alpha agonist stimulates mitochondrial fatty acid beta-oxidation in liver and skeletal muscle","volume":"280","author":"A Minnich","year":"2001","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"397","DOI":"10.3858\/emm.2009.41.6.045","article-title":"Fenofibrate inhibits adipocyte hypertrophy and insulin resistance by activating adipose PPARalpha in high fat diet-induced obese mice","volume":"41","author":"S Jeong","year":"2009","journal-title":"Exp Mol Med"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.phrs.2009.02.004","article-title":"The role of PPARalpha in lipid metabolism and obesity: focusing on the effects of estrogen on PPARalpha actions","volume":"60","author":"M Yoon","year":"2009","journal-title":"Pharmacol Res"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/0003-2697(78)90046-5","article-title":"Lipid extraction of tissues with a low-toxicity solvent","volume":"90","author":"A Hara","year":"1978","journal-title":"Analytic Biochem"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/sj.ijo.0802943","article-title":"Fenofibrate prevents Rosiglitazone-induced body weight gain in ob\/ob mice","volume":"29","author":"MC Carmona","year":"2005","journal-title":"Int J Obes (Lond)"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1093\/cvr\/cvp191","article-title":"Blockade of mineralocorticoid receptor reverses adipocyte dysfunction and insulin resistance in obese mice","volume":"84","author":"A Hirata","year":"2009","journal-title":"Cardiovasc Res"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method","volume":"25","author":"KJ Livak","year":"2001","journal-title":"Methods"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/nm.1904","article-title":"AdPLA ablation increases lipolysis and prevents obesity induced by high-fat feeding or leptin deficiency","volume":"15","author":"K Jaworski","year":"2009","journal-title":"Nat Med"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1194\/jlr.R400010-JLR200","article-title":"PPAR- and LXR-dependent pathways controlling lipid metabolism and the development of atherosclerosis","volume":"45","author":"AC Li","year":"2004","journal-title":"J Lipid Res"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"34182","DOI":"10.1074\/jbc.M204887200","article-title":"Stimulation of lipogenesis by pharmacological activation of the liver X receptor leads to production of large, triglyceride-rich very low density lipoprotein particles","volume":"277","author":"A Grefhorst","year":"2002","journal-title":"J Biol Chem"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"34036","DOI":"10.1074\/jbc.M109.051052","article-title":"Fenofibrate simultaneously induces hepatic fatty acid oxidation, synthesis, and elongation in mice","volume":"284","author":"MH Oosterveer","year":"2009","journal-title":"J Biol Chem"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/j.1440-1746.2011.06939.x","article-title":"Peroxisome proliferator-activated receptor-alpha agonist, Wy 14,643, improves metabolic indices, steatosis and ballooning in diabetic mice with non-alcoholic steatohepatitis","volume":"27","author":"CZ Larter","year":"2012","journal-title":"J Gastroenterol Hepatol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/j.bbrc.2006.02.032","article-title":"Adaptive failure to high-fat diet characterizes steatohepatitis in Alms1 mutant mice","volume":"342","author":"T Arsov","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1074\/jbc.M110.179499","article-title":"Liver X receptor (LXR) regulates human adipocyte lipolysis","volume":"286","author":"BM Stenson","year":"2011","journal-title":"J Biol Chem"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1210\/me.2001-0210","article-title":"On the role of liver X receptors in lipid accumulation in adipocytes","volume":"17","author":"LK Juvet","year":"2003","journal-title":"Mol Endocrinol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.biochi.2005.08.010","article-title":"Liver X receptor preferentially activates de novo lipogenesis in human preadipocytes","volume":"88","author":"C Darimont","year":"2006","journal-title":"Biochimie"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1194\/jlr.M700033-JLR200","article-title":"SREBP-1-independent regulation of lipogenic gene expression in adipocytes","volume":"48","author":"M Sekiya","year":"2007","journal-title":"J Lipid Res"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"5989","DOI":"10.1128\/MCB.22.16.5989-5999.2002","article-title":"Microarray analyses during adipogenesis: understanding the effects of Wnt signaling on adipogenesis and the roles of liver X receptor alpha in adipocyte metabolism","volume":"22","author":"SE Ross","year":"2002","journal-title":"Mol Cell Biol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1152\/physrev.00015.2003","article-title":"Brown adipose tissue: function and physiological significance","volume":"84","author":"B Cannon","year":"2004","journal-title":"Physiol Rev"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1073\/pnas.1017884108","article-title":"Both liver-X receptor (LXR) isoforms control energy expenditure by regulating brown adipose tissue activity","volume":"108","author":"M Korach-Andre","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"5128","DOI":"10.1210\/en.2008-0637","article-title":"Intestine-specific regulation of PPARalpha gene transcription by liver X receptors","volume":"149","author":"S Colin","year":"2008","journal-title":"Endocrinology"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.biochi.2012.09.028","article-title":"A systems biology approach to the hepatic role of the oxysterol receptor LXR in the regulation of lipogenesis highlights a cross-talk with PPARalpha","volume":"95","author":"S Ducheix","year":"2013","journal-title":"Biochimie"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1128\/MCB.06175-11","article-title":"Genome-wide profiling of liver X receptor, retinoid X receptor, and peroxisome proliferator-activated receptor alpha in mouse liver reveals extensive sharing of binding sites","volume":"32","author":"M Boergesen","year":"2012","journal-title":"Mol Cell Biol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s001250051193","article-title":"The RXR agonist LG100268 causes hepatomegaly, improves glycaemic control and decreases cardiovascular risk and cachexia in diabetic mice suffering from pancreatic beta-cell dysfunction","volume":"42","author":"JM Lenhard","year":"1999","journal-title":"Diabetologia"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1210\/me.2012-1151","article-title":"Fasting-induced FGF21 is repressed by LXR activation via recruitment of an HDAC3 corepressor complex in mice","volume":"26","author":"A Archer","year":"2012","journal-title":"Mol Endocrinol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.bbrc.2007.06.068","article-title":"PPARalpha is a key regulator of hepatic FGF21","volume":"360","author":"T Lundasen","year":"2007","journal-title":"Biochem Biophys Res Commun"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.cmet.2007.05.003","article-title":"Endocrine regulation of the fasting response by PPARalpha-mediated induction of fibroblast growth factor 21","volume":"5","author":"T Inagaki","year":"2007","journal-title":"Cell Metab"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.cell.2011.11.062","article-title":"Fibroblast growth factor-21 regulates PPARgamma activity and the antidiabetic actions of thiazolidinediones","volume":"148","author":"PA Dutchak","year":"2012","journal-title":"Cell"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1016\/j.febslet.2007.03.047","article-title":"T0901317 is a potent PXR ligand: implications for the biology ascribed to LXR","volume":"581","author":"N Mitro","year":"2007","journal-title":"FEBS Lett"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1172\/JCI200319451","article-title":"Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance","volume":"112","author":"H Xu","year":"2003","journal-title":"J Clin Invest"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1172\/JCI200319246","article-title":"Obesity is associated with macrophage accumulation in adipose tissue","volume":"112","author":"SP Weisberg","year":"2003","journal-title":"J Clin Invest"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/nm820","article-title":"Reciprocal regulation of inflammation and lipid metabolism by liver X receptors","volume":"9","author":"SB Joseph","year":"2003","journal-title":"Nat Med"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1161\/CIRCRESAHA.110.226878","article-title":"Liver x receptors in atherosclerosis and inflammation","volume":"108","author":"SS Im","year":"2011","journal-title":"Circ Res"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/j.bbalip.2007.04.021","article-title":"PPARalpha in atherosclerosis and inflammation","volume":"1771","author":"F Zandbergen","year":"2007","journal-title":"Biochim Biophys Acta"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1600-065X.2012.01153.x","article-title":"Liver X receptor and peroxisome proliferator-activated receptor as integrators of lipid homeostasis and immunity","volume":"249","author":"Y Kidani","year":"2012","journal-title":"Immunol Rev"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0065641","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,15]],"date-time":"2019-07-15T00:40:01Z","timestamp":1563151201000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0065641"}},"subtitle":[],"editor":[{"given":"Fran\u00e7ois","family":"Blachier","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2013,6,7]]},"references-count":48,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2013,6,7]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0065641","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,6,7]]}}}